RRL regis resources limited

2.23%

$4.39

Open letter to RRL Board & Management, page-71

First 71 Last

Share
Profile

Follow
Exised

6,849 Posts.

3507

08/01/20

12:22

Post #: 42281377
Share

Originally posted by Exised: ↑

We are not in production yet in NSW (McPhillamys), Duketon (WA) is humming like a well oiled machine according to the annual report in Dec and there are no fires there.

RRL's underperformance is due to its growth perception. RRL has an MO of growing organically while our peers (NST, EVN and SAR) have the perception of effectively applying M&A... For that MO, RRL will always have a niche in my portfolio. She is safe albeit a little too safe for some investors. I cannot fault Duketon operationally nor do I disagree that growing organically is a good approach. So far over the years the BOD have deployed earnings where it counts for early investors like me and that is on dividends. Building McPhillamys will take time but is a much safer approach in my opinion than M&A which a fraught with risk when the gold price is this high. But make no mistake RRL will pick up assets when the price is right and she will catch the Goldphoria when it matters.

Expand

Or "Fearphoria" by the looks of it... happy days and congrats to all that bough the Dec dip

RRL Price at posting: $4.57 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

'Not possible' to port renewable gas: ACCC takes AGN to court

First 71 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $4.39		Change -0.100(2.23%)		Mkt cap ! $3.316B

Open	High	Low	Value	Volume
$4.47	$4.53	$4.37	$16.81M	3.793M

Buyers (Bids)

No.	Vol.	Price($)
5	51252	$4.36

Sellers (Offers)

Price($)	Vol.	No.
$4.39	7201	1

View Market Depth

No.	Vol.	Price($)
5	51252	4.360
4	37004	4.350
2	24411	4.340
2	6157	4.310
5	37325	4.300

Price($)	Vol.	No.
4.390	7201	1
4.400	28087	1
4.410	38340	4
4.420	26563	3
4.430	15681	1

Last trade - 16.17pm 27/06/2025 (20 minute delay)

RRL (ASX) Chart

Open letter to RRL Board & Management, page-71

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Open letter to RRL Board & Management, page-71

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News